Molecular Infusions Patents – Insights & Stats (Updated 2023)

Molecular Infusions has a total of 22 patents globally, out of which no patents have been granted. Of these 22 patents, more than 22% patents are active. United States of America is where Molecular Infusions has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Molecular Infusions.

Molecular Infusions was founded in the year 2016. The Company is a patient-focused biopharmaceutical company committed to improving lives through advancing cannabis therapies.

Do read about some of the most popular patents of Molecular Infusions which have been covered by us in this article and also you can find Molecular Infusions patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Molecular Infusions patent portfolio.

How many patents does Molecular Infusions have?

Molecular Infusions has a total of 22 patents globally. These patents belong to 6 unique patent families. Out of 22 patents, 5 patents are active.

How Many Patents did Molecular Infusions File Every Year?

Molecular Infusions Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMolecular Infusions Applications FiledMolecular Infusions Patents Granted
20221
20212
20204
20197
20188

How many Molecular Infusions patents are Alive/Dead?

Molecular Infusions Patent Portfolio

How Many Patents did Molecular Infusions File in Different Countries?

Molecular Infusions Worldwide Patent Filing

Countries in which Molecular Infusions Filed Patents

CountryPatents
United States Of America5
Canada2
Europe2
Mexico1
Colombia1
China1
Israel1
Australia1
Japan1

Where are Research Centres of Molecular Infusions Patents Located?

The Research Centre for all the Molecular Infusions patents is the United States of America.

10 Best Molecular Infusions Patents

US20200037638A1 is the most popular patent in the Molecular Infusions portfolio. It has received 24 citations so far from companies like Tilray, Disruption Labs and Nulixir.

Below is the list of 10 most cited patents of Molecular Infusions:

Publication NumberCitation Count
US20200037638A124
US20200246404A114
CN110636834A11
US20200138072A16
JP2020509081A6
US20200253922A14
US20210299081A13
WO2021195173A13
CA3053158A12
WO2020092987A12

What Percentage of Molecular Infusions US Patent Applications were Granted?

Molecular Infusions (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Molecular Infusions patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Molecular Infusions?

Law FirmTotal ApplicationsSuccess Rate
Elmore Patent Law Group Pc50.00%

List of Molecular Infusions Patents

Molecular Infusions PatentsTitle
EP3582755A4Formulations
CA3117809A1Polymer-Based Oral Cannabinoid And/Or Terpene Formulations
CA3053158A1Formulations
MX2019009642AFormulations.
IL268697AFormulations
US20210299081A1Solid Cannabinoid Formulation For Oral Administration
US20200253922A1Methods For Non-Irritating Pulmonary Administration Of Cannabinoids Using Soft Mist Inhalers
US20200246404A1Formulations
US20200138072A1Polymer-Based Oral Cannabinoid And/Or Terpene Formulations
US20200037638A1Formulations
EP3873440A4Polymer-Based Oral Cannabinoid And/Or Terpene Formulations
CN110636834AFormulations
WO2022182844A1Purified Cannabinodis Isolated From Fermentate
WO2021195173A1Solid Cannabinoid Formulation For Oral Administration
WO2020167893A1Methods For Non-Irritating Pulmonary Administration Of Cannabinoids Using Soft Mist Inhalers
WO2020167892A1Methods For Non-Irritating Pulmonary Administration Of Cannabinoids Using Soft Mist Inhalers
WO2020092987A1Polymer-Based Oral Cannabinoid And/Or Terpene Formulations
WO2019036243A1Formulations
WO2018152334A1Formulations
JP2020509081APharmaceutical Formulation
CO20190009986A2Formulations
AU2018221739A1Formulations

What are Molecular Infusions key innovation segments?

What Technologies are Covered by Molecular Infusions?

The chart below distributes patents filed by Molecular Infusions in different countries on the basis of the technology protected in patents. It also represents the markets where Molecular Infusions thinks it’s important to protect particular technology inventions.

R&D Focus: How has Molecular Infusions search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Molecular Infusions?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.